Dr. Erica Schwartz Confirmed as CDC Director Amidst Deep-Seated Challenges and Public Health Turmoil
admin Dr. Erica Schwartz has been confirmed as the next director of the Centers for Disease...
biotech
Paving the Path to a Cancer-Free Future: The Enduring Impact of Legacy Giving to the Cancer Research Institute
Including the Cancer Research Institute (CRI) in your will is a personal and meaningful way...
Tarsus Pharmaceuticals Acquires Alkeus Pharmaceuticals in Up to $800 Million Deal, Advancing Stargardt Disease Treatment
Tarsus Pharmaceuticals, a prominent developer of treatments across ophthalmology, dermatology, and infectious diseases, has announced...
July: A Critical Call for UV Radiation Safety and Advances in Skin Cancer Immunotherapy
As July unfolds, marking Ultraviolet (UV) Radiation Safety Awareness Month, a renewed focus is cast...
FDA Grants Accelerated Approval to Replimune’s Tudriqev for Advanced Melanoma After Contentious Review Process
The U.S. Food and Drug Administration (FDA) has officially granted accelerated approval to Replimune’s novel...
The Evolving Landscape of Sarcoma Treatment: Immunotherapy Offers New Hope Amidst Complexity
Sarcoma, a rare and notably complex group of cancers, presents unique challenges for diagnosis and...
FDA Approves Orzeyful, a Groundbreaking Orexin-2 Agonist, Ushering in a New Era for Narcolepsy Type 1 Treatment
The U.S. Food and Drug Administration (FDA) has granted approval to Orzeyful, a novel medicine...
FDA Approves Moderna’s mFlusiva, Marking a Landmark Entry for mRNA Technology into Seasonal Flu Vaccination
The U.S. Food and Drug Administration (FDA) has granted approval for mFlusiva, previously known as...
Braveheart Bio Spearheads Biotech IPO Surge, As Five Firms Secure Over $1 Billion in Public Offerings This Week
Braveheart Bio, a rapidly emerging biotechnology company focused on cardiovascular therapies, has successfully completed its...
Novo Nordisk Faces Setbacks as Eli Lilly’s Injectable Franchise Continues to Outperform in Fierce GLP-1 Market
The intense rivalry between pharmaceutical giants Novo Nordisk and Eli Lilly in the burgeoning market...
